RxDoctor Payments Data

Kimberly Meyer

Acute Care · Louisville, KYNPI 1346233970

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Medtronic at 27.7% of the total. 2025 is the largest year on record at $1,395, 3.5 times the $403 reported in 2021.

$2,871in general payments, 2019–2025

Across 48 payments — averaging $59.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$794
  • Balt USA, LLC$527
  • Stryker$475
  • Microvention, Inc.$334
  • Penumbra, Inc.$237
  • AstraZeneca$140
  • plus $364 from 9 others

What the payments were for

  • Food & beverage$2,871100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,871 in reported general payments places this provider in the 85th percentile of 319 acute care providers in Kentucky.

See all acute care providers in Kentucky

Medicare billing

Part B allowed, 2024
$9,571
Medicare patients
94
Services billed
111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AmantadineAmantadine Hcl27$617
ClopidogrelClopidogrel Bisulfate43$397
Baclofen24$253
Amitriptyline Hcl17$243
Trazodone Hcl12$37

Paid to pharmacies, not to this prescriber.

Other acute care in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →